Bothell, WA, United States of America

Michael Edward Egan

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal2 out of 832,718 
Other
 patents

Years Active: 2017-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Edward Egan: Innovator in Microfluidic Technology

Introduction

Michael Edward Egan is a prominent inventor based in Bothell, Washington. With a focus on microfluidic technologies, he has made significant contributions to the field through his innovative patents. Egan is recognized for his work in developing systems that enhance biochemical processes, particularly in nucleic acid analysis.

Latest Patents

Egan holds two notable patents that showcase his expertise and innovative spirit. The first is a **Cartridge Interface Module (CIM)** designed for use in a nucleic acid analyzer system. This module is equipped with a fluidics component that enables the extraction of nucleic acids from biological samples within a removable microfluidic cartridge. It also includes a polymerase chain reaction (PCR) assembly component, high voltage electrodes for nucleic acid separation, and detection optics to analyze the fragments. These features collectively enhance the efficiency and accuracy of nucleic acid processing.

His second patent, **Non-contact Infrared Thermocycling**, involves a microfluidic chip with reaction chambers for chemical or biochemical reactions like PCR. This invention utilizes a non-contact heat source to heat the reaction chamber and the fluid simultaneously, improving control over the thermal cycling process essential for PCR. The inclusion of a temperature sensor and control circuitry ensures that the heating process aligns with the required cycling profile, optimizing reaction conditions.

Career Highlights

Michael Edward Egan’s career is marked by his commitment to advancing microfluidic technologies. His inventions have the potential to impact various fields, including medical diagnostics and research. With his two patents, he demonstrates a deep understanding of both the scientific and practical aspects of nucleic acid analysis.

Collaborations

Throughout his career, Egan has collaborated with experienced professionals such as James P. Landers and Brian Root. These partnerships are indicative of the collaborative spirit in the research community, allowing for the exchange of ideas and expertise that fosters innovation.

Conclusion

Michael Edward Egan is a distinguished inventor whose work in microfluidic technology is paving the way for advancements in biochemical analysis. His patents not only reflect his ingenuity but also contribute to the future of scientific research and diagnostics. As his career continues to evolve, Egan’s contributions will undoubtedly leave a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…